| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
George Massaro last filed a Form 4 in May 2025, as Director at HURN. The filings on record cover 2 companies. From January 2015 to May 2025, the filings on record show 0 open-market purchases and 47 sales. George Massaro's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns George Massaro a middling insider score of 66/100, based on 8 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +25.7%.
At the last filing, the largest reported position was 17,719 shares of HURN. The HURN filings lean toward selling, a net 16,838 shares.
Shares as reported in the last Form 4 for each company; the most recent is from May 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 2,899 | $114.14 | $330,881.03 | -17.0% | |
| Jun 25, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sell | 600 | $115.55 | $69,330.00 | -4.2% | |
| May 14, 2018 | CRL Charles River Laboratories International, Inc. | Director | Sell | 1,218 | $107.19 | $130,557.80 | -8.1% | |
| Apr 2, 2018 | HURN Huron Consulting Group Inc. | Director | Sell | 603 | $37.44 | $22,577.08 | -3.4% | |
| Jan 2, 2018 | HURN Huron Consulting Group Inc. | Director | Sell | 603 | $40.66 | $24,517.98 | -3.3% | |
| Oct 2, 2017 | HURN Huron Consulting Group Inc. | Director | Sell | 603 | $34.88 | $21,032.64 | -3.2% | |
| Jul 17, 2017 | CRL Charles River Laboratories International, Inc. | Director | Sale+OE | 3,830 | $100.81 | $386,103.39 | -20.4% | |
| Jul 17, 2017 | CRL Charles River Laboratories International, Inc. | Director | Sell | 200 | $101.38 | $20,276.00 | -1.3% | |
| Jul 3, 2017 | HURN Huron Consulting Group Inc. | Director | Sell | 602 | $43.31 | $26,072.62 | -3.1% | |
| May 12, 2017 | CRL Charles River Laboratories International, Inc. | Director | Sell | 1,130 | $88.30 | $99,784.20 | -7.1% |